Juergen A. Richt received his Doctorate in Veterinary Medicine (DVM) from the Ludwig-Maximilians-University Munich and PhD in Virology and Immunology from the Justus-Liebig-University Giessen (1988), both in Germany. Afterwards, he completed three years of postdoctoral/residency studies at The Johns Hopkins University in Baltimore, MD, USA. Next, Dr. Richt returned for eight years to the Justus-Liebig-University Giessen as a junior faculty to establish his own research program. He later served for eight years as a Veterinary Medical Officer at the National Animal Disease Center (USDA-ARS) in Ames, Iowa.
Dr. Richt came to Kansas State University in 2008 as The Regents Distinguished Professor and Kansas Bioscience Eminent Scholar. In 2010, he became Director of the Department of Homeland Security Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD), which is working with Principal Investigators in 16 different universities, as well as various industrial partners. His work in veterinary microbiology has focused mainly on the animal-human interface, called “One Health” that links human medicine, veterinary medicine and the environment. Dr. Richt has edited several books, published more than 190 peer-reviewed articles and raised more than $33 million in grants for veterinary research.
Zhao Yang Dong (M’99–SM’06-F'17) obtained Ph.D. degree from the University of Sydney, Australia in 1999. He is currently the SHARP professor and Director of the University of New South Wales Digital Grid Futures Institute, The University of New South Wales, Australia. He is also Director for ARC Research Hub for Integrated Energy Storage Solutions. He was previously Professor and Head of School of Electrical and Information Engineering, University of Sydney, and Ausgrid Chair and Director of the Ausgrid Centre for Intelligent Electricity Networks, the University of Newcastle, Australia. He also held industrial positions with Transend Networks (now TAS Networks), Australia. His research interests include smart grid, power system planning, power system security, renewable energy systems, electricity market, load modelling, and computational intelligence and its application in power engineering. He is serving/served as an editor of IEEE Transactions on Smart Grid, IEEE Power Engineering Letters, and IET Renewable Power Generation.HE is Fellow of IEEE.
Joep Geraedts (1948) obtained a BSc (1969) and MSc (1972) in general biology at the University of Nijmegen. At Leiden University he defended his PhD thesis in 1975. From 1982 to 2013 he was professor of Genetics and Cell Biology at Maastricht University and head of the Department of Clinical Genetics of the University Hospital. In 1995 he started the first and only licensed PGD programme in the Netherlands. He was chairman of the Dutch Society of Human Genetics (1984-1988); chairman of the Dutch Association of Clinical Genetics Centers (2000-2013), chairman of the European Society of Human Reproduction and Embryology (2007-2009) and member of the Dutch Health Council.
Dr. Michael Fossel obtained his PhD (Neurobiology) and his MD at Stanford University, where he had an NSF Fellowship, taught neuroanatomy, and began focusing on human aging, especially progeric syndromes. He practiced as a Clinical Professor of Medicine at Michigan State University for almost three decades and continues to teach the Biology of Aging at the university level.
He served as the executive director of the American Aging Association and is currently the medical advisor for the Dementia Society of America. He was founding Editor-in-Chief of Rejuvenation Research. He has published more than 80 articles, chapters, and books on aging and medicine, including Cells, Aging, and Human Disease (Oxford University Press). This magisterial text, with over 4,000 references, reviews the fields of telomere biology and cell aging, and remains the only textbook on the clinical potential of telomerase. His latest book, The Telomerase Revolution, discusses prospective FDA clinical trials of telomerase therapy as an effective intervention for Alzheimer’s disease. His book was named as one of the best five science books of 2015 by the Wall Street Journal. He is president of Telocyte, a biotech firm targeting Alzheimer’s disease.
Osamu Yokosuka is an Emeritus Professor of Chiba University, Japan. He graduated from Chiba University School of Medicine in 1975 then worked as a trainee under Professor K. Okuda in Chiba University Hospital till 1978. Dr. Yokosuka was a research fellow worked under Professor S. Scherlock and Professor B. H. Billing in Royal Free Hospital, London, UK from 1978 to 1980; under Professor M. Omata in Chiba University from 1980 to 1985; and under Dr. J Summers in Fox Chase Cancer Center, PA, USA in 1984. In 1985, he received a Degree of Doctor of Medical Science, and served as an Assistant Professor in Chiba University till 1994, then as Lecturer in Medicine till 2006 when he was appointed as Director and Professor of Medicine. From 2013 to 2015, he served as the Dean of Chiba University School of Medicine.
Dr. Yokosuka was the Secretary General of APASL (2008-2014). In 2016, he was elected as the President of APASL Tokyo, the President of 52nd Annual Meeting of Japan Society of Hepatology, and the President of Funabashi Central Hospital. Dr. Yokosuka’s research mainly focuses on Hepatitis and Hepatocellular Carcinoma. So far, he has published more than 700 original papers.
Tatsuo Kanda received a medical degree in 1991 at Niigata University School of Medicine, Japan, and his PhD in 1999 at Chiba University Graduate School of Medicine, Japan. He had post-doctor training for 3 years under Prof. Ratna Ray and Prof. Ranjit Ray at Saint Louis University, St. Louis, MO, USA. In Dec. 2008, Tatsuo Kanda became a Tenure-track Associate Professor at Department of Medicine and Clinical Oncology, Chiba University, Graduate School of Medicine, Japan. In Feb. 2013, Tatsuo Kanda was nominated a permanent Associate Professor at Department of Gastroenterology and Nephrology, Chiba University, Graduate School of Medicine, Japan. In 2017, Tatsuo Kanda became an Associate Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nihon University School of Medicine. For ~25 years, he has focused his scientific interests on the topics related to liver diseases including acute liver failure, viral hepatitis and autoimmune liver diseases, and worked with Prof. Osamu Yokosuka. Tatsuo Kanda is also an expert for hepatitis A virus (HAV), HBV and HCV, and translation and replication of these viruses, and hepatocarcinogenesis. With his expertise in antiviral therapies and hepatitis virus research, Tatsuo Kanda also sees a lot of patients in clinical daily practice. Tatsuo Kanda has published more than 200 articles in peer-reviewed Journal.
Gerhard Litscher obtained M.Sc. (Biomedical Engineering, 1984) and Ph.D. (Doctor of Technical Sciences, 1987) from Graz University of Technology, and M.D.sc. (Doctor of Medical Sciences, 2004) from Medical University of Graz, Austria. He has been leader or member of international professional societies, e.g., President of International Society for Medical Laser Applications (2012 to date); President of European Medical Laser Association-Austria (2012-2013); Vice president of International Medical Laser Association (2012 to date); Council Member of World Federation of Chinese Medicine Societies (2012-2016), etc. Now he is Professor and the head of (1) the Research Unit for Complementary and Integrative Laser Medicine, (2) the Research Unit of Biomedical Engineering in Anesthesia and Intensive Care Medicine, and (3) the TCM Research Center Graz at the Medical University of Graz. Professor Litscher’s special interests are computer-based High-Tech Acupuncture Research and Neuromonitoring. He has authored over 600 scientific publications and been invited for many lectures internationally. He is Visiting Professor and/or Honorary Professor of eleven universities and institutions in China.
Bart Ellenbroek received his PhD from the Radboud University in Nijmegen, the Netherlands, where he stayed as assistant and associate Professor until 2006. That year he moved to a biotech company in Hamburg, Germany where he was vice president of neuropharmacology until 2011, when he moved to the other side of the world, to New Zealand. He is currently Professor and deputy head of School at Victoria University of Wellington.
In Wellington, Bart leads the Behavioural Neurogenetics group at the school of psychology, which focusses on gene-environment interactions in psychiatry, using several genetic rat models. Although the main emphasis of their work is on behaviour, the research also involves recording ultrasonic vocalizations and physiological parameters such as heart rate and body temperature. The central research theme allows for a broad range of topics to be investigated, and within the group, students are working on schizophrenia, depression, autism spectrum disorders and drug addiction. For more information see http://www.behaviouralneurogenetics.com.
Pål-Dag Line graduated from the University of Oslo in 1987 and received his PhD degree from the University of Oslo in 1996. Since 2004 he has been Chairman at the Department of Surgery & Transplantation Medicine, Oslo University Hospital. He is board certified in general surgery, vascular surgery and transplant surgery. He holds the position as senior consultant surgeon and within the fields of abdominal transplantation (liver, kidney, pancreas), HPB surgery and vascular surgery as well as professor of surgery at the University of Oslo. He has a particular clinical and scientific experience and interest within the fields of living donation, abdominal vascular disease, liver transplantation, hepatocellular carcinoma, liver regeneration and immunotherapy. He is the Norwegian board member of the Scandinavian organ procurement organisation Scandiatransplant and member of the international transplantation societies TTS, ILTS and ESOT as well as the International Hepato-Pancreato-Biliary Association, European Surgical Association and International Surgical Group.
Prof. Frank Endres studied chemistry at the University of Saarbrücken, Germany, from 1988 to 1993 and obtained his PhD in Physical Chemistry in 1996 from the University of Saarbrücken. In 2002 he got his habilitation at Karlsruhe Institute of Technology and moved to the Clausthal University of Technology, where he established the Institute of Electrochemistry in 2013, after having declined a chair of Physical Chemistry at the University of Leipzig, Germany. He is a pioneer in the field of materials electrochemistry in ionic liquids and his research focuses on fundamentals and application of ionic liquids, nanoscale processes at the electrode/ionic liquid electrolyte interface, batteries and battery interfaces. He has published more than 200 scientific articles and delivered numerous invited lectures at prestigious conferences. He edited two books on the electrodeposition from ionic liquids and guest edited special issues on ionic liquids for the Royal Society of Chemistry. He is also an invited professor at the Harbin Institute of Technology, China.